The TLR7/8 agonist R848, known as resiquimod, is a member of the imidazoquinoline family and is an anti-inflammatory therapeutic agent that can be used to alleviate allergic asthma and chronic asthma via direct injection in mouse models. Here, TLR7 is linked to allergic asthma.